TNFSF10 and non-small cell lung carcinoma: A distinct separation in terms of cell viability between MSC-TRAIL and NSCLC cell lines was detected when the cells were treated with cisplatin at concentrations lower than 40 μM, indicating that treatments higher than 40 μM were highly toxic to all cells, including the MSCs (Figure 2A).